HeadFirst is a medical device company revolutionizing concussion detection with the first rapid, saliva-based screening tool designed for point-of-care use. Current concussion assessments rely on subjective tests and patient-reported symptoms, leading to missed injuries and delayed treatment. HeadFirst’s device delivers fast, objective results in minutes, enabling athletic trainers and healthcare professionals to make better decisions right on the sidelines or in clinical settings. Built on proprietary biomarker detection technology, our test combines scientific rigor with user-friendly design, making it accessible in sports, military, and emergency care environments. HeadFirst is advancing through analytical and clinical validation and preparing for regulatory submissions in key markets. Our vision is to empower safer participation in sports and protect brain health by ensuring every potential concussion is recognized and managed promptly.